Female w/ refractory follicular lymphoma who recently established care w/ Dr. [**First Name (STitle) **] and Dr. [**First Name (STitle) **].
Pt has history of complement mediated anaphylaxis reaction to Rituximab hence the elective admission for desensitization.
She underwent a retrial of Rituximab in [**2170**] with a slower rate of infusion, unfortunately she had the sensation of throat tightening and itching and the infusion was stopped.
On review of his history it appears he also has had significant fatigue over the past few weeks that was attributed to her pancytopenia.
with Follicular lymphoma in [**2168**] during work up of BOOP.
This treatment was complicated by febrile neutropenia and was discontinued.
BM bx showed increased celluarity with 70% of cellular material lymphoma cells consistent with her follicular lymphoma.
She was started on chlorambucil 4mg daily on approximately [**2172-11-13**] which was complicated by leukopenia and admission for anemia two weeks later.
Follicular Lymphoma (diagnosed [**2168**]-refractory) Bronchiolitis obliterans organizing pneumonia   Social History: The patient has three sons and three grandchildren.
She does not drive due to peripheral neuropathy.
Family History: NC  Physical Exam: GENERAL: Pleasant, well appearing Caucasian Female walking to bed from wheelchair in NAD HEENT: No scleral icterus.
No HSM EXTREMITIES: No edema or calf pain, 2+ dorsalis pedis/ posterior tibial pulses.
Peripheral neuropathy noted b/l LE to level of knee, b/l fingertips.
woman with follicular lymphoma and pancytopenia admitted to ICU for Rituximab desensitization.
She underwent bone marrow biopsy which showed a recurrence of her follicular lymphoma.
Given her thrombocytopenia and adverse effects on other regimens pt was admitted for Rituximab desensitization.
Pancytopenia: Pt has been pancytopenic over the past few weeks likely [**1-27**] lymphoma given her recent BM biopsy results.
Discharge Disposition: Home  Discharge Diagnosis: Primary: Rituximab desensitization Secondary: Pancytopenia, Anemia requiring blood transfusion, Neutropenia   Discharge Condition: Mental Status:Clear and coherent Level of Consciousness:Alert and interactive Activity Status:Ambulatory - Independent   Discharge Instructions: You were admitted to the hospital for the initiation of the Rituximab medication for your Follicular Lyphoma.
As you have a history of allergic reactions to this medication you underwent a 2 day protocol to be desensitized to this medication, you were able to tolerate a full dose without any allergic reactions.
As your blood and platelet counts were low you were also given blood and platelet transfusions.
If you experience any fevers, chills, extreme shivering, throat itching, swelling or difficulty breathing please return to the ED or call your doctor.
